Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Fennell

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Antisense & Nucleic Acid Drug Development|February 1, 1997
Quantitative antisense dose-response relationships: mathematical modeling of antisense action under steady-state conditionsD A Fennell
Journal of Theoretical Biology|March 10, 2001
A dynamical systems model to simulate the perturbation kinetics of gene expression by antisense oligonucleotidesD A Fennell, F E Cotter
Cytometry|March 30, 2000
Stochastic modeling of apoptosis tolerance distributions measured by multivariate flow analysis of human leukemia cellsD A Fennell, F E Cotter
Oncogene|September 11, 2007
BCL-2 family regulation by the 20S proteasome inhibitor bortezomibD A Fennell, A Chacko, L Mutti
Journal of Hypertension|June 1, 1990
Kinetics of the human leucocyte Na(+)-H+ antiport in essential hypertensionL L Ng, D A Fennell, C Dudley
British Journal of Cancer|May 18, 2001
Bcl-2 resistant mitochondrial toxicity mediated by the isoquinoline carboxamide PK11195 involves de novo generation of reactive oxygen speciesD A Fennell, M Corbo, A Pallaska, et al.
Apoptosis : an International Journal on Programmed Cell Death|April 22, 2005
Stochastic modelling of apoptosis kineticsD A Fennell, A Pallaska, M Corbo, et al.
Gut|September 18, 2002
Pk11195, a mitochondrial benzodiazepine receptor antagonist, reduces apoptosis threshold in Bcl-X(L) and Mcl-1 expressing human cholangiocarcinoma cellsA C Okaro, D A Fennell, M Corbo, et al.
British Journal of Cancer|June 10, 2011
Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancerA G Pallis, D A Fennell, E Szutowicz, et al.
British Journal of Haematology|March 22, 2001
In vivo suppression of Bcl-XL expression facilitates chemotherapy-induced leukaemia cell death in a SCID/NOD-Hu modelD A Fennell, M V Corbo, N M Dean, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Antisense & Nucleic Acid Drug Development|February 1, 1997
Quantitative antisense dose-response relationships: mathematical modeling of antisense action under steady-state conditionsD A Fennell
Journal of Theoretical Biology|March 10, 2001
A dynamical systems model to simulate the perturbation kinetics of gene expression by antisense oligonucleotidesD A Fennell, F E Cotter
Cytometry|March 30, 2000
Stochastic modeling of apoptosis tolerance distributions measured by multivariate flow analysis of human leukemia cellsD A Fennell, F E Cotter
Oncogene|September 11, 2007
BCL-2 family regulation by the 20S proteasome inhibitor bortezomibD A Fennell, A Chacko, L Mutti
Journal of Hypertension|June 1, 1990
Kinetics of the human leucocyte Na(+)-H+ antiport in essential hypertensionL L Ng, D A Fennell, C Dudley
British Journal of Cancer|May 18, 2001
Bcl-2 resistant mitochondrial toxicity mediated by the isoquinoline carboxamide PK11195 involves de novo generation of reactive oxygen speciesD A Fennell, M Corbo, A Pallaska, et al.
Apoptosis : an International Journal on Programmed Cell Death|April 22, 2005
Stochastic modelling of apoptosis kineticsD A Fennell, A Pallaska, M Corbo, et al.
Gut|September 18, 2002
Pk11195, a mitochondrial benzodiazepine receptor antagonist, reduces apoptosis threshold in Bcl-X(L) and Mcl-1 expressing human cholangiocarcinoma cellsA C Okaro, D A Fennell, M Corbo, et al.
British Journal of Cancer|June 10, 2011
Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancerA G Pallis, D A Fennell, E Szutowicz, et al.
British Journal of Haematology|March 22, 2001
In vivo suppression of Bcl-XL expression facilitates chemotherapy-induced leukaemia cell death in a SCID/NOD-Hu modelD A Fennell, M V Corbo, N M Dean, et al.
Pageof 3